ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer.To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with…

• A
  AstraZeneca
• FH
  F. Hoffmann-La Roche
• CO
  Clovis Oncology
• A
  Accuray
• DP
  Deciphera Pharmaceuticals
• S
  Seagen
• NO
  Nederlandse Organisatie voor Wetenschappelijk Onderzoek
• E
  Eisai
• ES
  EMD Serono